Liraglutide Improves Blood Sugar, Body Composition, and Metabolic Health
Liraglutide treatment improved glycemic dysregulation and body composition, demonstrating comprehensive metabolic benefits of GLP-1 receptor activation.
Quick Facts
What This Study Found
Liraglutide treatment improved glycemic dysregulation and body composition, demonstrating comprehensive metabolic benefits of GLP-1 receptor activation.
Key Numbers
Patients aged 12 to 17.9 years with severe obesity. Glycemic control assessed by continuous glucose monitoring (CGM).
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Liraglutide treatment improved glycemic dysregulation and body composition, demonstrating comprehens
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity.
- Published In:
- Journal of clinical research in pediatric endocrinology, 17(1), 68-75 (2025)
- Database ID:
- RPEP-09958
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Liraglutide treatment improved glycemic dysregulation and body composition, demonstrating comprehensive metabolic benefits of GLP-1 receptor activation.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09958APA
Apperley, Louise; Parkinson, Jennifer; Senniappan, Senthil. (2025). Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity.. Journal of clinical research in pediatric endocrinology, 17(1), 68-75. https://doi.org/10.4274/jcrpe.galenos.2024.2023-10-10
MLA
Apperley, Louise, et al. "Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity.." Journal of clinical research in pediatric endocrinology, 2025. https://doi.org/10.4274/jcrpe.galenos.2024.2023-10-10
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide Treatment Improves Glycaemic Dysregulation, Body..." RPEP-09958. Retrieved from https://rethinkpeptides.com/research/apperley-2025-liraglutide-treatment-improves-glycaemic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.